Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Neuropathic Pain Clinical Trial

Official title:

Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03544619
• Other study ID #: AYLIN2
• Status: Enrolling by invitation
• Start date: June 10, 2018
• Est. completion date: December 30, 2020

Study information

• Verified date: May 2020
• Source: Erenköy Physical Therapy and Rehabilitation Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

In this study, investigators want to perform the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Description:

The purpose of the study is to determine the Turkish version, the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory. 120 patients with neuropathic pain will be included in the study. Test-retest and internal consistency analysis were conducted to determine the reliability of the questionnaire. Test-retest results evaluated using the Intraclass Correlation Coefficient method.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 120
• Est. completion date: December 30, 2020
• Est. primary completion date: December 25, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age upper 18

• Complaints of neuropathic pain for at least 3 months

Exclusion Criteria:

• Presence of psychiatric illness

• Cancer pain, unsuccessful lumbar surgeon syndrome etc. mix type pain presence

• Presence of complex regional pain syndrome

• Cognitive impairment (mini-mental test score <24)

• Native language is not Turkish

Related Conditions & MeSH terms

• Neuralgia
• Neuropathic Pain

Intervention

Other:
• Neuropathic Pain Symptom Inventory
Investigators will use the Neuropathic Pain Symptom Inventory for assessing neuropathic symptoms

Locations

Country	Name	City	State
Turkey	Erenkoy Physical Treatment Nad Rehabilitation Hospital	I?stanbul

Sponsors (1)

Lead Sponsor	Collaborator
Erenköy Physical Therapy and Rehabilitation Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reliability and adaptation	Investigators will use linguistic validaiton guideline of Mapi research.	7 weeks
Primary	DN4	DN4 has become one of the principal condition-specific outcome measures of neuropathic pain.Investigators will use it for comparing results of NPSI.	5 minutes